Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

anti- IgG1, κ, A19-3, Hamster, BV650, Isotype Control, BD

Isotype Control

Manufacturer:  BD Biosciences 564388

Catalog No. BDB564388


Add to cart

Description

Description

The A19-3 monoclonal antibody specifically binds to the hapten, trinitrophenol (TNP). TNP is not expressed on human, mouse, or rat cells. The immunoglobulin from clone A19-3 was selected as an isotype control following screening for low background staining on a variety of mouse and human tissues.
The antibody was conjugated to BD Horizon™ BV650 which is part of the BD Horizon Brilliant™ Violet family of dyes. This dye is a tandem fluorochrome of BD Horizon BV421 with an Ex Max of 405nm and an acceptor dye with an Em Max at 650nm. BD Horizon BV650 can be excited by the violet laser and detected in a filter used to detect APC-like dyes (eg, 660/20nm filter). Due to the excitation and emission characteristics of the acceptor dye, there will be spillover into the APC and Alexa Fluor™ 700 detectors. However, the spillover can be corrected through compensation as with any other dye combination.

Applications:

Flow Cytometry, Isotype Control

Specifications

Specifications

Hamster IgG1, kappa
A19-3
Brilliant Violet 650
Hamster
IgG1, κ
4°C, protect from prolonged exposure to light, DO NOT FREEZE
Monoclonal
Flow Cytometry
0.2mg/mL
Affinity Purified
TNP-keyhole limpet hemocyanin
RUO
Primary
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit